Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-15

Clinical Trial Update: Cellentra Viable Cell Bone Matrix (VCBM) Anterior Cervical Discectomy and Fusion Outcomes Study (VCBM/MaxAn) [NA]

View source ↗

Summary

Clinical trial completion for Cellentra Viable Cell Bone Matrix (VCBM) in anterior cervical discectomy and fusion with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cellentra Viable Cell Bone Matrix (VCBM) (Cellentra Viable Cell Bone Matrix)

Snippet

Sponsor: Zimmer Biomet | Conditions: Cervical Disc Degenerative Disorder | NA | Status: COMPLETED | Results posted: 2019-03-15